Chapters

Transcript

Video

Robert Haddad, MD Discusses Head and Neck Cancer Research at AACR24

Important IMvoke010 trial could shape future research in immunotherapy in locally advanced head & neck cancer after results of 1st phase III study in adjuvant therapy don't meet event-free survival endpoint. Dana-Farber's Robert Haddad, MD, explains more in this video.


Published

April 10, 2024

Created by

Dana-Farber

Related Presenters

Robert I. Haddad, MD

Robert I. Haddad, MD

Medical Oncology

Dr Haddad received his MD Degree from St. Joseph University French School of Medicine in Beirut. He completed his residency in internal medicine at St Luke's Roosevelt Medical Center in New York City, and completed a fellowship in hematology ...

View full profile